Vitro Biopharma, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Vitro Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Vitro Biopharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending January 31, 2024 was $2.98M, a 666% increase year-over-year.
  • Vitro Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1.52M.
  • Vitro Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$1.11M.
  • Vitro Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2015 was $115K, a 6.87% decline from 2014.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.52M +$2.63M Nov 1, 2022 Oct 31, 2023 10-K 2024-01-29
2022 -$1.11M Nov 1, 2021 Oct 31, 2022 10-K 2024-01-29
2015 $115K -$8.47K -6.87% Nov 1, 2014 Oct 31, 2015 10-K 2016-09-22
2014 $123K +$8.98K +7.86% Nov 1, 2013 Oct 31, 2014 10-K 2016-09-22
2013 $114K -$24.7K -17.8% Nov 1, 2012 Oct 31, 2013 10-K 2015-02-13
2012 $139K +$31.2K +28.9% Nov 1, 2011 Oct 31, 2012 10-K 2014-02-12
2011 $108K -$48K -30.8% Nov 1, 2010 Oct 31, 2011 10-K 2013-02-12
2010 $156K Nov 1, 2009 Oct 31, 2010 10-K/A 2012-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.